Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus

IntroductionLipid control is essential in type 2 diabetes mellitus (T2DM). The aim of this study is to investigate factors associated with lipid therapy adherence and achievement of goals in real-life setting among patients with recently diagnosed T2DM.Research design and methodsThis is a longitudin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ open diabetes research & care 2021-02, Vol.9 (1), p.e001891, Article 001891
Hauptverfasser:	García-Ulloa, Ana Cristina, Lechuga-Fonseca, Claudia, Del Razo-Olvera, Fabiola Mabel, Aguilar-Salinas, Carlos Alberto, Galaviz, Karla Ivette, Narayan, K M Venkat, Hernández-Jiménez, Sergio
Format:	Artikel
Sprache:	eng
Schlagworte:	Cholesterol Chronic illnesses Diabetes Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Drug dosages Endocrinology Endocrinology & Metabolism Epidemiology/Health services research Female Goals Health surveys Humans Hypothyroidism Life Sciences & Biomedicine Lipids Low density lipoprotein Male Medical diagnosis Metabolism Middle Aged Normal distribution Patient compliance Pharmaceutical Preparations Prescription drugs Prescriptions Science & Technology Statins Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	IntroductionLipid control is essential in type 2 diabetes mellitus (T2DM). The aim of this study is to investigate factors associated with lipid therapy adherence and achievement of goals in real-life setting among patients with recently diagnosed T2DM.Research design and methodsThis is a longitudinal analysis in a center of comprehensive care for patients with diabetes. We include patients with T2DM,
ISSN:	2052-4897 2052-4897
DOI:	10.1136/bmjdrc-2020-001891